Posted on 5月 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on 11月 1, 202111/1/21
The Need for RWE Studies in APAC and the Impact on Product Life Cycle Management
Posted on 7月 14, 20217/14/21
Navigating the Transition to Post-Approval Pharmacovigilance With EVERSANA and ArisGlobal
Posted on 6月 15, 20216/15/21
PharmaVOICE Webinar: Next Gen Commercialization Model for Oncology
Posted on 6月 14, 20216/14/21
Omnichannel: A Conversation With the Innovators
Posted on 4月 26, 20214/26/21
Ask the Expert: How to Maximize Your Omnichannel Strategy
Posted on 3月 29, 20213/29/21
Turning Theory Into Action: How Real-World Evidence Drives Clinical Research and Improves Patient Outcomes
Posted on 3月 15, 20213/15/21
BLOG: Not So Rare… The True Impact of Rare Diseases
Posted on 2月 24, 20212/24/21